Hundreds of different mutations in genes encoding a few dozen sarcomeric proteins cause two reciprocal human disease phenotypes, hypertrophic or dilated cardiomyopathy. How molecular dysfunction evokes different patterns of cardiac remodeling is unclear. Davis et al. describe a biophysical metric of cardiomyocyte function, the force-time integral, which predicts disease phenotype.
The mammalian heart is a perpetually cycling muscular pump that circulates blood to meet metabolic demand. On a beat-to-beat basis, cardiac pump function is measured as ejection volume. Ejection performance depends upon intrinsic myocardial contractility, load (pressure) against which the heart is contracting, and geometric properties of the contracting chamber. The relationship between cardiac afterload and ventricular geometry is described by a modification of LaPlace's law, in which wall tension (T) / wall thickness (h) is directly proportional to blood pressure (P) times ventricular radius (R): T/h f P 3 R. In this issue of Cell, Davis et al. (2016) advance the notion that a biophysical feature of isolated cardiomyocytes with genetically abnormal sarcomeric function, the tension-(or force-) time integral, is a central determinant of whether the hearts will develop hypertrophic (HCM) or dilated (DCM) cardiomyopathy. Intriguingly, this functional metric appears to trump gene identity and molecular characteristics as a predictor of cardiac phenotype for genetic cardiomyopathies (Figure 1 ).
Hereditary conditions affecting cardiac sarcomeric proteins are classified according to heart morphology, rather than underlying genetic defect, in part because hundreds of different mutations provoke similar phenotypes. Moreover, different mutations within the same gene will sometimes induce opposing phenotypes (Morita et al., 2005; Hershberger et al., 2013) ; i.e., HCM with thick ventricular walls, normal internal ventricular dimensions, and normal ejection performance versus DCM with thin ventricular walls, enlarged ventricular chambers, and diminished ejection performance. Because cardiac remodeling and resulting changes in wall tension are a consequence, not the cause, of the primary genetic insult, the important question of how different genetic mutations involving cardiac sarcomeric proteins provoke either DCM or HCM remains unanswered. Davis et al. (2016) re-examine this paradigm using a systems approach to evaluate multiple functional indices in reciprocal mouse phenotypes provoked by well-characterized functionally opposite mutations of the calcium-sensing thin filament sarcomeric protein, cardiac troponin C (cTnC). The L48Q mutation that increases cTnC calcium sensitivity and enhances force development induces HCM-like features (in mice with chronically depressed heart rates), whereas the I61Q mutation that decreases cTnC calcium sensitivity provokes lethal DCM. Functional analyses of cardiomyocytes with 50% replacement of endogenous L48Q or I61Q cTnC reveal that the forcetime integral, i.e., the total amount of tension generated during a single cardiomyocyte contraction, was superior to individual indices of rate, extent of calcium cycling, or cardiomyocyte shortening in classifying cardiac phenotype.
In engineering terms, the integral of force produced over time is a measure of isotonic work. The current findings therefore relate work performed by genetically altered sarcomeres to cardiac remodeling, linking function of the basic unit of cardiac contraction to overall organ structure. Hearts in which sarcomeres are performing more work (i.e., having an increased force-time integral) develop concentric remodeling and HCM. By comparison, hearts in which sarcomeres are work-impaired (i.e., having a decreased force-time integral) develop eccentric remodeling and DCM. The idea that cardiomyocyte work is a determinant of ventricular remodeling in genetic cardiomyopathies is consistent with the notion that increased or decreased sarcomere power generation (power = work performed per unit of time) is an underlying determinant of HCM versus DCM (Debold et al., 2007) . Collectively, these ideas support therapeutic efforts targeting sarcomere power generation to counteract the consequences of genetic mutations on sarcomere function (Green et al., 2016) .
Cardiomyocyte enlargement and its macroscopic counterpart, increased heart mass, occur in both HCM and DCM. However, HCM cardiomyocytes enlarge in the short axis by creating more sarcomeres in parallel, thus sharing the work of developing tension across more contractile units. In contrast, DCM cardiomyocytes enlarge in the long axis by generating additional sarcomeres in series, which can additively increase the extent of cardiomyocyte shortening but does little to decrease the tension experienced by each sarcomere. These differences in cardiomyocyte remodeling may contribute to observed differences in the force-time integrals between HCM and DCM.
The translational promise of the tension-time integral model is its application to heart disease caused by rare or poorly characterized mutations. Here, predictive accuracy is key even if underlying processes are unclear. Thus, a potentially damaging mutation in one or more genes encoding a sarcomeric protein (detected by genome sequencing) would trigger generation of inducible pluripotent stem (iPS) cells from which iPS-derived cardiomyocytes (iPS-CMs) could be produced. Evaluation of cardiomyocyte tension-time relations would anticipate if the offending mutation was more likely to provoke either DCM or HCM (or neither). Davis et al. (2016) present data from a small number of human HCM and DCM subjects supporting the feasibility of this approach. Independent validation of predictive accuracy for a greater diversity of mutations and demonstrating that variability in iPSCMs will not confound results will be essential to propel this approach toward the bedside.
The scientific value of any mathematical model is its potential to explain mechanistic underpinnings of complex biological processes. Here, predictive accuracy is necessary, but not sufficient. The straightforward integrated tensionindex model is attractive in part because it distills the convergent functional consequences of perturbations of calcium cycling (Minamisawa et al., 1999) , altered sensitivity of the contractile apparatus to calcium (Seidman and Seidman, 2001) , changes in the intrinsic force-generating capacity of the contractile system (Debold et al., 2007) , and the modulatory effects of adrenergic tone (Liggett et al., 2000) ( Figure 1 ). However, it is a cardiomyocyte-specific metric and does not account for pathological influences of extracellular factors, including myocardial matrix expansion, myofibrillar disarray, and cardiomyocyte dropout. Moreover, some findings are subject to differing interpretations: for example, is generalized redistribution of calcium to or away from the sarcomere more important than specific changes in cTnC calcium on/off rates evoked by the L48Q and I61Q mutations? It is also notable that prolonging diastole through b-adrenergic receptor blockade unmasked HCM in the L48Q mouse, whereas b-blockers alleviate symptoms in human HCM precisely because they slow the heart rate and enhance diastolic filling (Spirito et al., 1997) .
A project as ambitious and complex as this is inherently susceptible to criticism. This research involves 11 different genetic combinations in mice, integrates these data with findings in human iPS-derived cardiomyocytes, and proposes a novel mechanistic concept supported by a mathematical model: there is ample fodder for nitpicking. The authors deserve kudos for generating vast amounts of data supporting the tension-time integral relationship with HCM and DCM. We look forward to examinations of this paradigm in other mouse models and the exploratory application of its predictive value in human subjects with rare, poorly characterized sarcomere gene mutations. Molecular and environmental factors on the left are related to heritable cardiomyopathy phenotype (right) as a function of the cardiomyocyte force-time integral (center) described by Davis et al. (2016) . Gene mutations in cardiac myosin heavy chain (MYH7) that alter myofilament force potential, in phospholamban (PLN) that alter calcium cycling, and in troponin C (TNNC1) that alter calcium sensitivity to contraction cause either hypertrophic (HCM) or dilated (DCM) cardiomyopathy in human patients: these disease phenotypes are recapitulated in mouse models. Endogenous adrenergic activation by environmental stressors can modify the cardiac response to these primary genetic insults. The cumulative functional impact of these individual factors is reflected in the isolated cardiomyocyte force-(or tension-) time integral, a measure of the total mechanical work performed during a single contraction-relaxation cycle. Independent of the specific characteristics of the input factors, and whether they act singly or combinatorially, the force-time integral predicts the nature of cardiac geometric remodeling and therefore whether the resulting disease is HCM or DCM.
